Naming Treatment for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on testing a new treatment for aphasia, a language disorder often caused by a stroke that affects both speaking and understanding words. The trial explores the effectiveness and tolerability of a new naming treatment, called Criterion-learning Based Naming Treatment, which uses retrieval practice to improve word recall and comprehension. As a single-arm study, all participants receive the same treatment, which could eventually be used at home to support traditional therapy. Individuals who have had a stroke at least six months ago, speak English as their primary language, and do not have other neurological conditions might be suitable for this trial. As an unphased trial, this study offers the opportunity to contribute to innovative research that could enhance future aphasia treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this treatment is safe for people with aphasia?
Research has shown that the Criterion-learning Based Naming Treatment for aphasia has been studied in several projects. Although the studies do not detail specific safety data for this treatment, it relies on well-known methods like errorless learning and word retrieval. These methods are commonly used in language therapy and are generally safe for patients.
The treatment involves computer-based naming exercises for people with aphasia, a language disorder often caused by strokes. These therapies are usually considered safe because they focus on language practice rather than medications or medical procedures. However, as with any treatment, individual experiences can vary, so healthcare professionals must monitor participants to ensure the treatment remains safe for them.12345Why are researchers excited about this trial?
Researchers are excited about Criterion-learning Based Naming Treatment for aphasia because it offers a unique approach compared to traditional speech therapies. Unlike standard treatments that often focus on repetitive practice, this method uses a criterion-learning approach, which tailors the learning process to meet specific performance benchmarks. This personalized method has the potential to enhance the brain's ability to relearn language more effectively. By targeting the specific areas where patients struggle, this technique could lead to faster and more sustainable improvements in naming and language use.
What evidence suggests that this treatment might be an effective treatment for aphasia?
Research has shown that the Criterion-learning Based Naming Treatment may benefit people with aphasia, a language disorder often occurring after strokes. Some studies have found that this treatment can enhance naming abilities, with participants becoming more accurate in naming objects. For instance, individuals trained with this method scored 1.6 points higher on naming tests like the Boston Naming Test. Early results also suggest that practicing word retrieval can significantly improve naming and understanding words. While individual results may vary, these findings offer promise for those interested in a trial to improve language skills affected by aphasia.16789
Who Is on the Research Team?
Erica L Middleton, PhD
Principal Investigator
Albert Einstein Healthcare Network
Are You a Good Fit for This Trial?
This trial is for adults who have had a stroke at least 6 months ago and primarily speak English. It's designed to help those with aphasia, which is a language disorder affecting speech and comprehension.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a multi-session naming treatment study with criterion-learning practice, involving five training sessions generally separated by one week.
Retention Test
A retention test of naming performance is administered approximately one week following the final training session to assess naming mastery.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with additional retention tests approximately one week and one month post-treatment.
What Are the Treatments Tested in This Trial?
Interventions
- Criterion-learning Based Naming Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Albert Einstein Healthcare Network
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Thomas Jefferson University
Collaborator